{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:13:58Z","timestamp":1761884038006,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.reumae.2020.10.005","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:19:54Z","timestamp":1644477594000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications"],"prefix":"10.1016","volume":"18","author":[{"given":"Yasser","family":"Emad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwa","family":"El-Shaarawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Fawzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"El-Makhzangy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ossama","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes J.","family":"Rasker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2020.10.005_bib0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.28.4.394","article-title":"Histopathology of intestinal inflammation related to reactive arthritis","volume":"28","author":"Cuvelier","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.reumae.2020.10.005_bib0165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.10.005_bib0170","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s10620-011-1633-y","article-title":"Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease","volume":"56","author":"Aomatsu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.reumae.2020.10.005_bib0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.33549\/physiolres.930448","article-title":"Calprotectin-a pleiotropic molecule in acute and chronic inflammation","volume":"53","author":"Str\u00edz","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.reumae.2020.10.005_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/flgastro-2013-100420","article-title":"Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?","volume":"6","author":"Dhaliwal","year":"2015","journal-title":"Frontl Gastroenterol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17550","article-title":"Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Tech Assess"},{"key":"10.1016\/j.reumae.2020.10.005_bib0190","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s10620-011-1633-y","article-title":"Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease","volume":"56","author":"Aomatsu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.reumae.2020.10.005_bib0195","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3748\/wjg.15.2443","article-title":"Gastrointestinal lesions associated with spondyloarthropathies","volume":"15","author":"Orlando","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11926-002-0061-6","article-title":"Gut inflammation and spondyloarthropathies","volume":"4","author":"De Keyser","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.reumae.2020.10.005_bib0205","article-title":"The colon and terminal ileum in patients with ankylosing spondylitis and controls in Bangladesh. A macroscopic and microscopic study","volume":"2","author":"Ferdous","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.reumae.2020.10.005_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/art.1780370105","article-title":"High frequency of silent inflammatory bowel disease in spondylarthropathy","volume":"37","author":"Leirisalo-Repo","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2020.10.005_bib0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.10.005_bib0220","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2020.10.005_bib0225","first-page":"182","article-title":"The diagnostic dilemma of undifferentiated inflammatory synovitis of the knee joint\/joints: a comprehensive approach","volume":"10","author":"Emad","year":"2007","journal-title":"APLAR J"},{"key":"10.1016\/j.reumae.2020.10.005_bib0230","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3899\/jrheum.081320","article-title":"Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging?","volume":"36","author":"Emad","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0235","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3899\/jrheum.120301","article-title":"Knee Enthesitis Working Group. Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms","volume":"39","author":"Emad","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10067-010-1655-4","article-title":"Enthesitis in seronegative spondyloarthropathies with special attention to the knee joint by MRI: a step forward toward understanding disease pathogenesis","volume":"30","author":"Yasser","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0245","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.10.005_bib0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3899\/jrheum.161216","article-title":"Detection of crohn disease in patients with spondyloarthropathy: the SpACE capsule study","volume":"45","author":"Kopylov","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009742.2017.1299216","article-title":"Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis","volume":"47","author":"\u00d8stg\u00e5rd","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2020.10.005_bib0265","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.10.005_bib0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-016-1180-1","article-title":"Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"18","author":"Levitova","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2020.10.005_bib0275","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1038\/s41598-018-32199-3","article-title":"Association of circulating calprotectin with lipid profile in axial spondyloarthritis","volume":"8","author":"Genre","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2020.10.005_bib0280","doi-asserted-by":"crossref","first-page":"7574147","DOI":"10.1155\/2017\/7574147","article-title":"Discriminating value of calprotectin in disease activity and progression of nonradiographic axial spondyloarthritis and ankylosing spondylitis","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.reumae.2020.10.005_bib0285","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10067-014-2663-6","article-title":"Wnt signaling in ankylosing spondylitis","volume":"33","author":"Corr","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3899\/jrheum.180432","article-title":"Added value of fecal calprotectin to support the diagnosis of spondyloarthropathies","volume":"46","author":"VanHoovels","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0295","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.berh.2018.08.012","article-title":"Gut inflammation in spondyloarthritis","volume":"31","author":"Rizzo","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0300","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.reumae.2020.10.005_bib0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.10.005_bib0310","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/ph3041084","article-title":"Non steroidal anti-inflammatory drugs and inflammatory bowel disease","volume":"3","author":"Klein","year":"2010","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:02:08Z","timestamp":1761879728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574322000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2173574322000156"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2020.10.005","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}